RxDoctor Payments DataLook up a doctor →

Anna McFather, PA

Medical · Athens, GANPI 1124501184

Payments from drug & device makers

$13,131in general payments, 2019–2025

Across 593 payments — averaging $22.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$2K
  • Johnson & Johnson$813
  • Merck$800
  • Daiichi Sankyo Inc.$647
  • Takeda Pharmaceuticals U.S.A., Inc.$516
  • Eisai Inc.$467
  • plus $8K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis55$1,791
Johnson & Johnson(2 entities)41$813
Merck36$800
Daiichi Sankyo Inc.31$647
Takeda Pharmaceuticals U.S.A., Inc.15$516
Eisai Inc.22$467
Seagen Inc.21$446
GSK24$435
Pharmacyclics LLC, An Abbvie Company17$416
AstraZeneca(2 entities)21$414
Sanofi16$387
Gilead(2 entities)21$360
Bristol Myers Squibb13$353
Amgen17$329
Pfizer18$314
Exelixis Inc.14$292
Incyte Corporation15$277
AbbVie11$274
Regeneron Healthcare Solutions, Inc.13$267
Bayer11$233
Jazz Pharmaceuticals Inc.10$228
Karyopharm Therapeutics Inc.10$218
Genentech USA, Inc.10$213
Sobi, Inc8$178
Beigene USA, Inc.8$167
Adaptive Biotechnologies Corporation6$166
Puma Biotechnology, Inc.8$150
Epizyme, Inc.8$147
Ipsen Biopharmaceuticals, Inc6$128
Astellas Pharma US Inc5$119
ADC Therapeutics America, Inc.6$108
Tersera Therapeutics LLC5$106
Deciphera Pharmaceuticals Inc.4$96
Rigel Pharmaceuticals, Inc.4$89
Lilly USA, LLC4$81
EMD Serono, Inc.5$79
AVEO Pharmaceuticals, Inc.3$71
Sumitomo Pharma America, Inc.3$64
G1 Therapeutics, Inc.3$60
Stemline Therapeutics Inc.2$57
Blueprint Medicines Corporation3$57
Servier Pharmaceuticals LLC3$55
E.r. Squibb & Sons, L.L.C.3$51
Coherus Oncology, Inc.3$49
Pharmaessentia USA Corporation2$45
Apellis Pharmaceuticals, Inc.2$39
Array Biopharma Inc3$39
Genmab U.S., Inc.2$37
Mirati Therapeutics, Inc.2$32
Heron Therapeutics, Inc.2$31
Acrotech Biopharma Inc.2$29
Delcath Systems1$26
EUSA Pharma (US) LLC1$26
Taiho Oncology, Inc.1$24
CTI Biopharma Corp.1$24
Legend Biotech USA Inc.1$22
Novocure Inc.1$22
Pharmacosmos Therapeutics Inc.1$21
Recordati_rare_diseases_inc.1$20
Geron Corporation1$19

How this compares

$13,131 in reported general payments places this provider in the 95th percentile of 950 medical providers in Georgia.

See all medical providers in Georgia →

Medicare billing

Part B allowed, 2024
$18,704
Medicare patients
26
Services billed
852

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical in Athens

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →